À LA UNE de l'actualité médicale
The key treatment with curative intent in high-risk acute myeloid leukaemia (AML) is allogeneic haematopoietic stem cell transplantation. Unfortunately, there remains the persistent risk of relapse after transplant. The most common sites of relapse apart from the bone marrow are the skin, gastrointestinal system and central nervous system (CNS). Ocular relapse, in contrast, is a more uncommon site...
Tong M. H. et al.
Case Reports in Ophthalmological Medicine 2024 (2024), Article ID 2235819, 5 pages
Lire la suite
Tong M. H. et al.
Case Reports in Ophthalmological Medicine 2024 (2024), Article ID 2235819, 5 pages
Lire la suite
Renal transplant rejection is an immunological response in a recipient to recognition of foreign antigen in an allograft [1]. Acute allograft rejection can occur as early as one week posttransplant, with the highest risk in the first three months [2]. Acute T-cell mediated rejection (TCMR) is due to cytotoxic T-cell reaction to human leukocyte antigens (HLA) on the donor kidney [3]. Acute antibody-mediated...
Gupta Simran et al.
Journal of Transplantation 2024 (2024), Article ID 6663086, 9 pages
Lire la suite
Gupta Simran et al.
Journal of Transplantation 2024 (2024), Article ID 6663086, 9 pages
Lire la suite
Hematopoietic stem cell transplantation (HSCT) is the standard of care for several hematological malignancies, and certain congenital or acquired disorders [1].
The availability of stem cell transplant programs has been impacted by differences in resource availability between industrialized and developing nations [2]. At the time of writing this manuscript, HSCT programs in Africa are only available...
Rwezaula Stella et al.
Advances in Hematology 2024 (2024), Article ID 1937419, 10 pages
Lire la suite
Rwezaula Stella et al.
Advances in Hematology 2024 (2024), Article ID 1937419, 10 pages
Lire la suite